Company Overview

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

  • Name

    Eurofins Scientific SE

  • CEO

    Dr. Gilles G. Martin Ph.D.

  • Website

    www.eurofins.com

  • Sector

    Life Sciences Tools and Services

  • Year Founded

    1987

Profile

  • Market Cap

    €10.02B

  • EV

    €12.93B

  • Shares Out

    191.37M

  • Revenue

    €6,723.8M

  • Employees

    61,798

Margins

  • Gross

    22.19%

  • EBITDA

    19.45%

  • Operating

    12.2%

  • Pre-Tax

    7.5%

  • Net

    5.64%

  • FCF

    11.12%

Returns (5Yr Avg)

  • ROA

    5.47%

  • ROTA

    15.51%

  • ROE

    12.06%

  • ROCE

    12.05%

  • ROIC

    8.57%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €60.34

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €681.2M

  • Net Debt

    €2,862.9M

  • Debt/Equity

    0.67

  • EBIT/Interest

    5.8

Growth (CAGR)

  • Rev 3Yr

    1.72%

  • Rev 5Yr

    9.84%

  • Rev 10Yr

    17.87%

  • Dil EPS 3Yr

    -26%

  • Dil EPS 5Yr

    16.35%

  • Dil EPS 10Yr

    16.8%

  • Rev Fwd 2Yr

    7.76%

  • EBITDA Fwd 2Yr

    11.33%

  • EPS Fwd 2Yr

    13.13%

  • EPS LT Growth Est

    12.15%

Dividends

  • Yield

  • Payout

    29.6%

  • DPS

    €0.5

  • DPS Growth 3Yr

    -9.74%

  • DPS Growth 5Yr

    11.66%

  • DPS Growth 10Yr

    15.34%

  • DPS Growth Fwd 2Yr

    22.34%

ENXTPA:ERF